LAM
ELV icon

Lyrical Asset Management’s Elevance Health ELV Stock Holding History

Lyrical Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,522,468
Closed -$400M – 34
2018
Q4 		$400M Sell
1,522,468
-353,299
-19% -$97.1M 6.04% 3
2018
Q3 		$514M Buy
1,875,767
+35,731
+2% +$9.28M 6.19% 2
2018
Q2 		$438M Buy
1,840,036
+16,290
+0.9% +$3.77M 5.47% 2
2018
Q1 		$401M Buy
1,823,746
+98,815
+6% +$23.2M 4.9% 2
2017
Q4 		$388M Buy
1,724,931
+33,243
+2% +$7.08M 4.74% 2
2017
Q3 		$321M Buy
1,691,688
+49,156
+3% +$9.36M 4.19% 3
2017
Q2 		$309M Buy
1,642,532
+185,754
+13% +$33.4M 4.35% 3
2017
Q1 		$241M Buy
1,456,778
+70,686
+5% +$11.2M 3.87% 5
2016
Q4 		$199M Buy
1,386,092
+34,511
+3% +$4.62M 3.55% 7
2016
Q3 		$169M Sell
1,351,581
-49,962
-4% -$6.45M 3.32% 10
2016
Q2 		$184M Buy
1,401,543
+43,931
+3% +$6.01M 3.84% 5
2016
Q1 		$189M Buy
1,357,612
+198,277
+17% +$26.5M 4.11% 3
2015
Q4 		$162M Buy
1,159,335
+22,797
+2% +$3.14M 3.97% 4
2015
Q3 		$158M Buy
1,136,538
+89,554
+9% +$13.5M 3.76% 4
2015
Q2 		$172M Buy
1,046,984
+116,201
+12% +$18.6M 4.49% 3
2015
Q1 		$144M Buy
930,783
+181
+0% +$25.8K 4.3% 2
2014
Q4 		$117M Buy
930,602
+159,369
+21% +$19.7M 3.55% 6
2014
Q3 		$92.3M Buy
771,233
+115,562
+18% +$13.3M 3.6% 5
2014
Q2 		$70.6M Buy
655,671
+119,201
+22% +$12.3M 3.08% 8
2014
Q1 		$53.4M Buy
536,470
+71,105
+15% +$6.43M 2.99% 15
2013
Q4 		$43M Buy
465,365
+181,934
+64% +$16.2M 2.75% 23
2013
Q3 		$23.7M Buy
283,431
+61,777
+28% +$5.29M 2.79% 22
2013
Q2 		$18.1M Buy
+221,654
New +$16.6M 2.95% 20

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lyrical Asset Management's ELV Position: Q1 2019 in Review

Lyrical Asset Management sold out of Elevance Health (ELV) in Q1 2019, closing a stake of 1,522,468 shares — an estimated $400M sold.

Lyrical Asset Management first reported a position in ELV in Q2 2013 and held it in 23 quarters. The position peaked at $514M in Q3 2018. 1,076 funds tracked by Wall St. Rank hold ELV as of Q1 2019.

  • Lyrical Asset Management reported no remaining Elevance Health position as of Q1 2019 after selling out during the quarter.
  • Lyrical Asset Management sold 1,522,468 Elevance Health shares in Q1 2019, an estimated $400M.
  • Lyrical Asset Management first reported a position in Elevance Health in Q2 2013 and held it in 23 quarters.
  • Lyrical Asset Management's Elevance Health position peaked at $514M in Q3 2018.
  • 1,076 funds tracked by Wall St. Rank held Elevance Health as of Q1 2019.

Based on Lyrical Asset Management's 13F filing for Q1 2019, filed 15 May 2019.